Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria - Better Therapeutics (NASDAQ:BTTX)
Naim Alkhouri, MD, FAASLD, to Present Findings from Non-alcohol Related Fatty Liver Disease Feasibility Study Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) company developing a